Results 221 to 230 of about 2,601,816 (350)
Clinical trial barriers in neurostimulation for pediatric drug‐resistant epilepsy
Abstract Objective The NeuroPace responsive neurostimulation (RNS) System effectively treats focal drug‐resistant epilepsy (DRE) in adults but lacks pediatric regulatory approval. Despite effective off‐label pediatric use, systemic device‐trial challenges have impeded label expansion.
Mira C. Hasner +15 more
wiley +1 more source
[X-linked intellectual disability syndrome with macrocephaly due to BRWD3 gene deletion]. [PDF]
Arroyo-Carrera I +4 more
europepmc +1 more source
Inhibition of histone deacetylation rescues phenotype in a mouse model of Birk-Barel intellectual disability syndrome. [PDF]
Cooper A +12 more
europepmc +1 more source
Heart Transplant for Noncompaction Cardiomyopathy in NONO ‐Related Syndromic Intellectual Disability
Julia S. Singer +5 more
openalex +1 more source
Abstract Objective Rasmussen's encephalitis (RE) is a rare and progressive, immune‐mediated epileptic encephalopathy characterized by drug‐resistant seizures and neurological decline. While hemispheric disconnection (HD) is the gold standard treatment for effective seizure control, this procedure carries significant risk of permanent neurological ...
Krish Nair +11 more
wiley +1 more source
Abstract Objective To compare the incidence of hostility‐ and aggression‐related adverse events in children with focal‐onset seizures (FOS), with or without focal to bilateral tonic–clonic seizures (FBTCS), receiving perampanel as monotherapy or in combination with other antiseizure medications (ASMs).
Yukitoshi Takahashi +5 more
wiley +1 more source
Microphthalmia-ankyloblepharon-intellectual disability syndrome [PDF]
openaire +1 more source

